img

Global Haemophilus Influenzae Type B Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Haemophilus Influenzae Type B Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Haemophilus influenzae b is the leading cause of death and morbidity in children, and its six entities are meningitis, bacterial pneumonia, epiglottitis, septicaemia, cellulitis and bone and joint infections.HIB disease is the cause of about 90 percent of child deaths each year.HIB vaccines are effective and safe for infants because they contain polyribonitol phosphate that binds to proteins in response to meningitis and pneumonia in children.
Haemophilus Influenzae Type B Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Haemophilus Influenzae Type B Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Research Institutions are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Haemophilus Influenzae Type B Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Haemophilus Influenzae Type B Vaccine key manufacturers include Novartis, Merck, Sanofi, GlaxoSmithKline, Takeda Pharmaceuticals Company, Walvax Biotechnology, Lanzhou Institute of Biologica and Immunize BC, etc. Novartis, Merck, Sanofi are top 3 players and held % sales share in total in 2022.
Haemophilus Influenzae Type B Vaccine can be divided into Liquid Monovalent HIB, Liquid Combination HIB, Lyophilized Monovalent HIB and Lyophilized Combination HIB, etc. Liquid Monovalent HIB is the mainstream product in the market, accounting for % sales share globally in 2022.
Haemophilus Influenzae Type B Vaccine is widely used in various fields, such as Hospital, Research Institutions, Pharmaceutical and Biotechnology Companies and Academic Institutions, etc. Hospital provides greatest supports to the Haemophilus Influenzae Type B Vaccine industry development. In 2022, global % sales of Haemophilus Influenzae Type B Vaccine went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Haemophilus Influenzae Type B Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Merck
Sanofi
GlaxoSmithKline
Takeda Pharmaceuticals Company
Walvax Biotechnology
Lanzhou Institute of Biologica
Immunize BC
Segment by Type
Liquid Monovalent HIB
Liquid Combination HIB
Lyophilized Monovalent HIB
Lyophilized Combination HIB

Segment by Application


Hospital
Research Institutions
Pharmaceutical and Biotechnology Companies
Academic Institutions
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Haemophilus Influenzae Type B Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Haemophilus Influenzae Type B Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Haemophilus Influenzae Type B Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Haemophilus Influenzae Type B Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Haemophilus Influenzae Type B Vaccine introduction, etc. Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Haemophilus Influenzae Type B Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Haemophilus Influenzae Type B Vaccine Market Overview
1.1 Haemophilus Influenzae Type B Vaccine Product Overview
1.2 Haemophilus Influenzae Type B Vaccine Market Segment by Type
1.2.1 Liquid Monovalent HIB
1.2.2 Liquid Combination HIB
1.2.3 Lyophilized Monovalent HIB
1.2.4 Lyophilized Combination HIB
1.3 Global Haemophilus Influenzae Type B Vaccine Market Size by Type
1.3.1 Global Haemophilus Influenzae Type B Vaccine Market Size Overview by Type (2024-2034)
1.3.2 Global Haemophilus Influenzae Type B Vaccine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Haemophilus Influenzae Type B Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Haemophilus Influenzae Type B Vaccine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Haemophilus Influenzae Type B Vaccine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Haemophilus Influenzae Type B Vaccine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Breakdown by Type (2024-2024)
2 Global Haemophilus Influenzae Type B Vaccine Market Competition by Company
2.1 Global Top Players by Haemophilus Influenzae Type B Vaccine Sales (2024-2024)
2.2 Global Top Players by Haemophilus Influenzae Type B Vaccine Revenue (2024-2024)
2.3 Global Top Players by Haemophilus Influenzae Type B Vaccine Price (2024-2024)
2.4 Global Top Manufacturers Haemophilus Influenzae Type B Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Haemophilus Influenzae Type B Vaccine Market Competitive Situation and Trends
2.5.1 Haemophilus Influenzae Type B Vaccine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Haemophilus Influenzae Type B Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Haemophilus Influenzae Type B Vaccine Market
2.8 Key Manufacturers Haemophilus Influenzae Type B Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Haemophilus Influenzae Type B Vaccine Status and Outlook by Region
3.1 Global Haemophilus Influenzae Type B Vaccine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Haemophilus Influenzae Type B Vaccine Historic Market Size by Region
3.2.1 Global Haemophilus Influenzae Type B Vaccine Sales in Volume by Region (2024-2024)
3.2.2 Global Haemophilus Influenzae Type B Vaccine Sales in Value by Region (2024-2024)
3.2.3 Global Haemophilus Influenzae Type B Vaccine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Haemophilus Influenzae Type B Vaccine Forecasted Market Size by Region
3.3.1 Global Haemophilus Influenzae Type B Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Haemophilus Influenzae Type B Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Haemophilus Influenzae Type B Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Haemophilus Influenzae Type B Vaccine by Application
4.1 Haemophilus Influenzae Type B Vaccine Market Segment by Application
4.1.1 Hospital
4.1.2 Research Institutions
4.1.3 Pharmaceutical and Biotechnology Companies
4.1.4 Academic Institutions
4.1.5 Other
4.2 Global Haemophilus Influenzae Type B Vaccine Market Size by Application
4.2.1 Global Haemophilus Influenzae Type B Vaccine Market Size Overview by Application (2024-2034)
4.2.2 Global Haemophilus Influenzae Type B Vaccine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Haemophilus Influenzae Type B Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Haemophilus Influenzae Type B Vaccine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Haemophilus Influenzae Type B Vaccine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Haemophilus Influenzae Type B Vaccine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Breakdown by Application (2024-2024)
5 North America Haemophilus Influenzae Type B Vaccine by Country
5.1 North America Haemophilus Influenzae Type B Vaccine Historic Market Size by Country
5.1.1 North America Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2024-2024)
5.1.3 North America Haemophilus Influenzae Type B Vaccine Sales in Value by Country (2024-2024)
5.2 North America Haemophilus Influenzae Type B Vaccine Forecasted Market Size by Country
5.2.1 North America Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Haemophilus Influenzae Type B Vaccine Sales in Value by Country (2024-2034)
6 Europe Haemophilus Influenzae Type B Vaccine by Country
6.1 Europe Haemophilus Influenzae Type B Vaccine Historic Market Size by Country
6.1.1 Europe Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2024-2024)
6.1.3 Europe Haemophilus Influenzae Type B Vaccine Sales in Value by Country (2024-2024)
6.2 Europe Haemophilus Influenzae Type B Vaccine Forecasted Market Size by Country
6.2.1 Europe Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Haemophilus Influenzae Type B Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Haemophilus Influenzae Type B Vaccine by Region
7.1 Asia-Pacific Haemophilus Influenzae Type B Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Haemophilus Influenzae Type B Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales in Value by Region (2024-2034)
8 Latin America Haemophilus Influenzae Type B Vaccine by Country
8.1 Latin America Haemophilus Influenzae Type B Vaccine Historic Market Size by Country
8.1.1 Latin America Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Haemophilus Influenzae Type B Vaccine Sales in Value by Country (2024-2024)
8.2 Latin America Haemophilus Influenzae Type B Vaccine Forecasted Market Size by Country
8.2.1 Latin America Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Haemophilus Influenzae Type B Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Haemophilus Influenzae Type B Vaccine by Country
9.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Novartis Haemophilus Influenzae Type B Vaccine Products Offered
10.1.5 Novartis Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Merck Haemophilus Influenzae Type B Vaccine Products Offered
10.2.5 Merck Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Products Offered
10.3.5 Sanofi Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Information
10.4.2 GlaxoSmithKline Introduction and Business Overview
10.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Products Offered
10.4.5 GlaxoSmithKline Recent Development
10.5 Takeda Pharmaceuticals Company
10.5.1 Takeda Pharmaceuticals Company Company Information
10.5.2 Takeda Pharmaceuticals Company Introduction and Business Overview
10.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Products Offered
10.5.5 Takeda Pharmaceuticals Company Recent Development
10.6 Walvax Biotechnology
10.6.1 Walvax Biotechnology Company Information
10.6.2 Walvax Biotechnology Introduction and Business Overview
10.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Products Offered
10.6.5 Walvax Biotechnology Recent Development
10.7 Lanzhou Institute of Biologica
10.7.1 Lanzhou Institute of Biologica Company Information
10.7.2 Lanzhou Institute of Biologica Introduction and Business Overview
10.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Products Offered
10.7.5 Lanzhou Institute of Biologica Recent Development
10.8 Immunize BC
10.8.1 Immunize BC Company Information
10.8.2 Immunize BC Introduction and Business Overview
10.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Products Offered
10.8.5 Immunize BC Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Haemophilus Influenzae Type B Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Haemophilus Influenzae Type B Vaccine Industrial Chain Analysis
11.4 Haemophilus Influenzae Type B Vaccine Market Dynamics
11.4.1 Haemophilus Influenzae Type B Vaccine Industry Trends
11.4.2 Haemophilus Influenzae Type B Vaccine Market Drivers
11.4.3 Haemophilus Influenzae Type B Vaccine Market Challenges
11.4.4 Haemophilus Influenzae Type B Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Haemophilus Influenzae Type B Vaccine Distributors
12.3 Haemophilus Influenzae Type B Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Liquid Monovalent HIB
Table 2. Major Company of Liquid Combination HIB
Table 3. Major Company of Lyophilized Monovalent HIB
Table 4. Major Company of Lyophilized Combination HIB
Table 5. Global Haemophilus Influenzae Type B Vaccine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2024-2024) & (M Doses)
Table 7. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2024-2024) & (US& Million)
Table 9. Global Haemophilus Influenzae Type B Vaccine Market Share in Value by Type (2024-2024)
Table 10. Global Haemophilus Influenzae Type B Vaccine Price by Type (2024-2024) & (USD/Dose)
Table 11. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2024-2034) & (M Doses)
Table 12. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type (2024-2034)
Table 15. Global Haemophilus Influenzae Type B Vaccine Price by Type (2024-2034) & (USD/Dose)
Table 16. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2024-2024) & (M Doses)
Table 17. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2024-2024)
Table 19. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2024-2024)
Table 21. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2024-2024)
Table 23. Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2024-2024)
Table 25. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Haemophilus Influenzae Type B Vaccine Sales by Company (2024-2024) & (M Doses)
Table 27. Global Haemophilus Influenzae Type B Vaccine Sales Share by Company (2024-2024)
Table 28. Global Haemophilus Influenzae Type B Vaccine Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Company (2024-2024)
Table 30. Global Market Haemophilus Influenzae Type B Vaccine Price by Company (2024-2024) & (USD/Dose)
Table 31. Global Haemophilus Influenzae Type B Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Haemophilus Influenzae Type B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2022)
Table 34. Date of Key Manufacturers Enter into Haemophilus Influenzae Type B Vaccine Market
Table 35. Key Manufacturers Haemophilus Influenzae Type B Vaccine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Haemophilus Influenzae Type B Vaccine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2024-2024) & (M Doses)
Table 39. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Region (2024-2024)
Table 42. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 43. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2024-2034) & (M Doses)
Table 44. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Region (2024-2034)
Table 47. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 48. Global Haemophilus Influenzae Type B Vaccine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2024) & (M Doses)
Table 50. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application (2024-2024)
Table 53. Global Haemophilus Influenzae Type B Vaccine Price by Application (2024-2024) & (USD/Dose)
Table 54. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2034) & (M Doses)
Table 55. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application (2024-2034)
Table 58. Global Haemophilus Influenzae Type B Vaccine Price by Application (2024-2034) & (USD/Dose)
Table 59. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2024) (M Doses)
Table 60. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2024) (M Doses)
Table 62. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2024) (M Doses)
Table 64. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2024) (M Doses)
Table 66. Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2024) (M Doses)
Table 68. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2024) & (M Doses)
Table 70. North America Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Country (2024-2024)
Table 73. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2034) & (M Doses)
Table 74. North America Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2024) & (M Doses)
Table 78. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2034) & (M Doses)
Table 82. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2024-2024) & (M Doses)
Table 86. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2024-2034) & (M Doses)
Table 90. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2024) & (M Doses)
Table 94. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2034) & (M Doses)
Table 98. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2024) & (M Doses)
Table 102. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2034) & (M Doses)
Table 106. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Country (2024-2034)
Table 109. Novartis Company Information
Table 110. Novartis Introduction and Business Overview
Table 111. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 112. Novartis Haemophilus Influenzae Type B Vaccine Product
Table 113. Novartis Recent Development
Table 114. Merck Company Information
Table 115. Merck Introduction and Business Overview
Table 116. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 117. Merck Haemophilus Influenzae Type B Vaccine Product
Table 118. Merck Recent Development
Table 119. Sanofi Company Information
Table 120. Sanofi Introduction and Business Overview
Table 121. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 122. Sanofi Haemophilus Influenzae Type B Vaccine Product
Table 123. Sanofi Recent Development
Table 124. GlaxoSmithKline Company Information
Table 125. GlaxoSmithKline Introduction and Business Overview
Table 126. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 127. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product
Table 128. GlaxoSmithKline Recent Development
Table 129. Takeda Pharmaceuticals Company Company Information
Table 130. Takeda Pharmaceuticals Company Introduction and Business Overview
Table 131. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 132. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product
Table 133. Takeda Pharmaceuticals Company Recent Development
Table 134. Walvax Biotechnology Company Information
Table 135. Walvax Biotechnology Introduction and Business Overview
Table 136. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 137. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product
Table 138. Walvax Biotechnology Recent Development
Table 139. Lanzhou Institute of Biologica Company Information
Table 140. Lanzhou Institute of Biologica Introduction and Business Overview
Table 141. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 142. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product
Table 143. Lanzhou Institute of Biologica Recent Development
Table 144. Immunize BC Company Information
Table 145. Immunize BC Introduction and Business Overview
Table 146. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 147. Immunize BC Haemophilus Influenzae Type B Vaccine Product
Table 148. Immunize BC Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Haemophilus Influenzae Type B Vaccine Market Trends
Table 152. Haemophilus Influenzae Type B Vaccine Market Drivers
Table 153. Haemophilus Influenzae Type B Vaccine Market Challenges
Table 154. Haemophilus Influenzae Type B Vaccine Market Restraints
Table 155. Haemophilus Influenzae Type B Vaccine Distributors List
Table 156. Haemophilus Influenzae Type B Vaccine Downstream Customers
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Haemophilus Influenzae Type B Vaccine Product Picture
Figure 2. Global Haemophilus Influenzae Type B Vaccine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Haemophilus Influenzae Type B Vaccine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Haemophilus Influenzae Type B Vaccine Sales Status and Outlook (2024-2034) & (M Doses)
Figure 5. Product Picture of Liquid Monovalent HIB
Figure 6. Global Liquid Monovalent HIB Sales YoY Growth (2024-2034) & (M Doses)
Figure 7. Product Picture of Liquid Combination HIB
Figure 8. Global Liquid Combination HIB Sales YoY Growth (2024-2034) & (M Doses)
Figure 9. Product Picture of Lyophilized Monovalent HIB
Figure 10. Global Lyophilized Monovalent HIB Sales YoY Growth (2024-2034) & (M Doses)
Figure 11. Product Picture of Lyophilized Combination HIB
Figure 12. Global Lyophilized Combination HIB Sales YoY Growth (2024-2034) & (M Doses)
Figure 13. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2022 & 2034
Figure 15. North America Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. North America Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Haemophilus Influenzae Type B Vaccine Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Haemophilus Influenzae Type B Vaccine Revenue in 2022
Figure 27. Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2024-2034) & (M Doses)
Figure 30. Product Picture of Research Institutions
Figure 31. Global Research Institutions Sales YoY Growth (2024-2034) & (M Doses)
Figure 32. Product Picture of Pharmaceutical and Biotechnology Companies
Figure 33. Global Pharmaceutical and Biotechnology Companies Sales YoY Growth (2024-2034) & (M Doses)
Figure 34. Product Picture of Academic Institutions
Figure 35. Global Academic Institutions Sales YoY Growth (2024-2034) & (M Doses)
Figure 36. Product Picture of Other
Figure 37. Global Other Sales YoY Growth (2024-2034) & (M Doses)
Figure 38. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application in 2022 & 2034
Figure 40. North America Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. North America Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application in 2022
Figure 43. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application in 2022
Figure 46. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Haemophilus Influenzae Type B Vaccine Manufacturing Cost Structure
Figure 51. Haemophilus Influenzae Type B Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries